JOHN FARMER to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications JOHN FARMER has written about Randomized Controlled Trials as Topic.
Connection Strength
0.278
-
Adjunctive interventions in myocardial infarction: the role of statin therapy. Curr Atheroscler Rep. 2008 Apr; 10(2):142-8.
Score: 0.050
-
Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nat Clin Pract Cardiovasc Med. 2006 Dec; 3(12):664-72.
Score: 0.046
-
Intensive versus moderate lipid lowering with statins in acute coronary syndromes. Curr Atheroscler Rep. 2005 Mar; 7(2):85-6.
Score: 0.041
-
Reversal of atherosclerosis with aggressive lipid lowering. Curr Atheroscler Rep. 2005 Mar; 7(2):86-7.
Score: 0.041
-
Benefits of simvastin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):93-4.
Score: 0.035
-
Benefits of atorvastatin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):94-5.
Score: 0.035
-
Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf. 2000 Sep; 23(3):197-213.
Score: 0.030